Water Filters and Improved Cookstoves in Western Rwanda

Assessing the Health Impact of Advance Water Filters and Improved Cookstoves in Western Province, Rwanda: A Cluster-randomised Controlled Trial

DelAgua Health Rwanda (Implementation) Ltd. together with Rwanda Ministry of Health (MoH) are delivering an intervention, consisting on the free distribution of one advance water filter and one improved cookstove to all household classified as ubudehe 1 and 2 according to government approved registers (poorest tertile), in Western Province. The aim of this intervention is to reduce the morbidity and mortality associated with diarrhoeal diseases and pneumonia in Rwanda.

The London School of Hygiene and Tropical Medicine (LSHTM) will be undertaking an independent evaluation of this large-scale intervention to assess its impact on health. The trial will evaluate whether the provision of improved cookstoves and advance water filters can reduce pneumonia and diarrhoea disease in children under 5 years of age.

A cluster randomized controlled trial (CRCT) with two arms of unequal size (3:1 ratio) will be use to answer this question. The 96 sectors in Western Province, Rwanda, will be randomised to either receive the intervention or the control. Each eligible household in intervention sectors will receive one EcoZoom™ Spartan and one Vestergaard Frandsen Lifestraw Family™ 2.1 water filter free of charge. Eligible households in control sectors will continue with their traditional cooking and drinking practices. Health data on children under 5 years of age will be collected from community health worker (CHW) and health facility records all across Western Province to evaluate the health impact of the intervention. The study will encompass 12 months of follow-up. After this time the control sectors will receive the intervention.

This independent evaluation will also include a nested village-level study within the larger sector-level study, with the aim to evaluate uptake, consistent use and acceptability of the intervention, as well as to assess the impact on environmental exposures and health outcomes. 174 villages (74 controls and 74 intervention) will be selected for participation. Household surveys will be used to collect data on intervention use and acceptability as well as on self-reported health data. Water samples will be collected and monitoring of exposure to Households Air Pollution (HAP) will be undertaken. Measurements of blood pressure, expirated Carbon monoxide (CO) and pulse CO-oximetry will be undertake in primary cooks and or children under 5 years of age. Additionally, as part of this nested study, two exploratory studies will also be conducted. One will be focused on assessing the potential of biomarkers as indicators of environmental exposures (mainly HAP and water quality) and health status, while the other exploratory sub-study will assess the reactivity of participants to the use of remotely reporting electronic sensors to measure target behaviours.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1582

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kigali, Rwanda, PO Box 1594
        • Manna Energy Ltd.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • For Sector-level study:
  • All households shown on updated 2012 government registers to be members of ubudehe 1 and 2 in Western Province, Rwanda will be eligible to participate in the study.
  • For nested village-level study:
  • All villages from all sectors in Western province, according to official Government lists will be eligible for participation with the exception of those villages that were selected for participation in Phase 1.
  • At the village-level, all households that are classified as ubudehe 1 & 2 according to updated 2012 government registers, are part of the village, are able to provide informed consent, and that have at least one child under 4 years of age at the time of enrollment will be eligible for participation. Presence of a child under 4 years of age will be assessed by checking dates of birth or recorded age in months in the CHW register of children <5 years (Igitabo Cy'Ibikorwa Byo Gukurikirana), which are maintained at the village by CHW (though occasionally these are transferred to health centers). If this data is missing will be assesses based on CHW's report. In those cases where a village has more than the required number of participating households (10 household), a random selection of 10 households will be drawn.
  • For the assessment of personal exposure to HAP a stricter set of eligibility criteria will be applied. Households that comply with the following eligibility criteria will be eligible for the exposure to HAP sub-study.

    • Have a child 1.5-4 year old,
    • Have a child healthy enough to wear the monitoring equipment (as perceived by the mother),
    • Have a non-smoking primary cook,
    • Have a primary cook that is currently not pregnant (as far as she is aware of), and
    • Have a primary cook that is in a healthy state to wear the monitoring equipment
  • The first two households identified from a randomised list will be invited to participate.
  • For the biomarker sub-studies, both the primary cook and the child under 4 years of age from households undergoing HAP exposure assessment will be eligible for the inflammatory cytokine biomarker study. For the enteric seroconversion study, all children aged 6 to 12 months will be eligible for participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Water filter and cookstove
All household that appear on Government approved lists as belonging to ubudehe 1 & 2 categories in the 72 sectors randomised as intervention sectors will be eligible to receive one free water filtering device and one free cookstove. All households will be given instructions of how to use the intervention.
The Vestergaard Frandsen Lifestraw Family™ 2.1 is a point-of-use water treatment system.Water is poured through a 20 micron pre-filter into a 6L influent water tank.This water then filters through a 0.20 micron hollow-fiber ultrafiltration membrane into a 5.5L storage container.Water is then poured through a plastic tap, which prevents re-contamination.This system filters up to 18,000L of water.The system exceeds the WHO's "highly protective" standard for household water treatment technologies.The EcoZoom™ Spartan stove concentrates the combustion process while channeling airflow to completely burn the fuel provided.The stove has a ceramic combustion chamber within a steel housing, which is topped with a cast iron stove.The stove includes a rack for placing firewood and a pot skirt that improves the thermal efficiency.The cookstoves and filters will be delivered together at no cost to participating households.Households will receive instructions on how to operate these devices.
Other Names:
  • Vestergaard Frandsen Lifestraw Family™ 2.1
  • EcoZoom™ Spartan
No Intervention: Control
All household that appear on Government approved lists as belonging to ubudehe 1 & 2 categories in the 24 sectors randomised as control sectors will continue with their traditional cooking methods and drinking practices.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of IMCI defined pneumonia in children under 5 years of age in ubudehe 1 & 2 categories
Time Frame: 12 months
All types of pneumonia (severe, non severe). This outcome measure will be assessed in the sector-level study.
12 months
Incidence of IMCI defined diarrhoea in children under 5 years of age in ubudehe 1 & 2 categories
Time Frame: 12 months
All types of diarrhoea (including severe, persistent, dysentery). This outcome measure will be assessed in the sector-level study.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All-cause mortality in children under 5 years of age in ubudehe 1 & categories
Time Frame: 12 months
This outcome measure will be assessed in the sector-level study.
12 months
Incidence of maternal health outcomes among women un ubudehe 1 & 2 categories
Time Frame: 12 months
Incidence of maternal health outcomes including low birth weight, premature birth, and still birth
12 months
Prevalence of self-reported diarrhoea in children under 5 years of age in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Prevalence of pneumonia in children under 5 years of age in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of IMCI defined pneumonia in children under 5 years of age in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Prevalence of IMCI defined diarrhoea in children under 5 years of age in ubudehe 1 &2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Prevalence of self-reported diarrhoea among primary cooks
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Prevalence of self-reported respiratory conditions among primary cooks in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Mena difference in blood pressure in primary cooks in ubudehe 1 and 2 categories
Time Frame: 12 months
Mean difference of systolic and diastolic measured separately. This outcome measure will be assessed in the nested village-level study.
12 months
Mean difference in levels of expirated CO in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Mean difference levels of Carboxyhaemoglobin in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Percentage seroconversion against enteric pathogens in children 6-12 months of age at enrolment in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Mean difference in inflammatory cytokines in children under 5 years of age in unudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Median difference in 48-h personal exposure to PM2.5 in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study.
12 months
Levels of faecal contamination in drinking water
Time Frame: 12 months
This outcome measure will be assessed in the nested village-level study. Proportion of water samples samples free of faecal contamination.
12 months
Levels of consistent use of the intervention
Time Frame: 12 months

This outcome measure will be assessed in the intervention group only of the nested village-level study.

Percentage of households reporting the use of the stove as their primary stove in all follow-up visits. Percentage of households reporting their current drinking water was treated by the intervention filter in all follow-up visits.

12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

September 9, 2014

First Submitted That Met QC Criteria

September 11, 2014

First Posted (Estimate)

September 12, 2014

Study Record Updates

Last Update Posted (Estimate)

September 12, 2016

Last Update Submitted That Met QC Criteria

September 9, 2016

Last Verified

February 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Clinical Trials on Water filter and cookstove

3
Subscribe